Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy.
Olencki T, Finke J, Tubbs R, Tuason L, Greene T, McLain D, Swanson SJ, Herzog P, Stanley J, Edinger M, Budd GT, Bukowski RM.
Olencki T, et al. Among authors: budd gt.
J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):69-80. doi: 10.1097/00002371-199601000-00008.
J Immunother Emphasis Tumor Immunol. 1996.
PMID: 8859726
Clinical Trial.